Lipid metabolism disorders (including inborn errors of lipid metabolism) are illnesses where trouble occurs in breaking down or synthesizing fats (or fat-like substances).
Biomedical research is persistently striving for the development of new therapeutics based on peptides and proteins by introducing both structural and functional specific modifications and maintaining the features responsible for biological activity - peptidomimetics.
Protein–protein interactions (PPIs) play a central role in many cellular processes and are involved in numerous pathways, including different stages of cancer development, host–pathogen interactions, and other diseases.